Bladder cancer cells may upregulate enzymes like tryptophan 2,3-dioxygenase (TDO) or indoleamine 2,3-dioxygenase (IDO), leading to heightened tryptophan degradation. Here, TDO2 is linked to urinary bladder carcinoma.